Streetbeat News

Stock Prices

SKY

Wedbush analyst Jay McCanless has downgraded Skyline Champion (NYSE:SKY) from Outperform to Neutral and set a price target of $72.

Portfolio Pulse from Benzinga Newsdesk

December 18, 2023 | 12:49 pm

TMHC

Wedbush analyst Jay McCanless has downgraded Taylor Morrison Home (NYSE:TMHC) from Outperform to Neutral and set a price target of $52. This change reflects a revised outlook on the company's stock by the analyst.

Portfolio Pulse from Benzinga Newsdesk

December 18, 2023 | 12:47 pm

TPH

Wedbush analyst Jay McCanless has downgraded Tri Pointe Homes (NYSE:TPH) from Outperform to Neutral and set a price target of $32.

Portfolio Pulse from Benzinga Newsdesk

December 18, 2023 | 12:45 pm

SGML

Sigma Lithium Corporation (NASDAQ:SGML) is advancing its Strategic Review Process, with the Board of Directors encouraged by ongoing negotiations with potential strategic partners. The company plans to list Sigma Brazil on both Nasdaq and the Singapore Stock Exchange to facilitate a strategic transaction and maximize shareholder value. CEO Ana Cabral expressed delight at the interest from global leaders in the battery materials and electric vehicle industries. The company aims to leverage its position as a low-cost, Net Zero lithium producer to expand its global presence and capitalize on its competitive advantage.

Portfolio Pulse from Benzinga Newsdesk

December 18, 2023 | 12:45 pm

VRAX

Virax Biolabs Group Limited (VRAX) CEO James Foster issued a shareholder letter detailing the company's progress in immunology research, particularly in post viral syndromes and chronic inflammation. The company has developed a SARS-Cov-2 version of its ViraxImmune T-Cell Kit and is collaborating with a UK research institute. Virax is also enhancing its IVD platform with FluoroSpot technology for better immune response analysis. Financially, Virax is in a strong position with $5.6 million in cash and no debt after a warrant exercise in October 2023. The stock is currently trading at 57% of cash value. The company anticipates significant advancements in its FluoroSpot assays and expansion of distribution channels in the next 12 months.

Portfolio Pulse from Benzinga Newsdesk

December 18, 2023 | 12:44 pm

SPWR

Goldman Sachs analyst Brian Lee has downgraded SunPower (NASDAQ:SPWR) from Neutral to Sell and reduced the price target from $5 to $4.

Portfolio Pulse from Benzinga Newsdesk

December 18, 2023 | 12:42 pm

GTLS

KEQU

OOMA

Insiders at Ooma, Chart Industries, and Kewaunee Scientific have recently made notable stock purchases. Ooma's CEO and President Eric B Stang bought 10,000 shares at $9.85 each. Chart Industries' Director Linda Harty purchased 1,000 shares at $130.14 each, despite the company reporting worse-than-expected Q3 results and lowering its full year 2023 sales guidance. Kewaunee Scientific's Director John Russell acquired 7,500 shares at $22.98 each after the company posted a Q2 profit.

Portfolio Pulse from Avi Kapoor

December 18, 2023 | 12:39 pm

AADI

DRRX

KTRA

The article highlights three health care stocks that are considered oversold based on their Relative Strength Index (RSI) values, suggesting a potential buying opportunity for undervalued companies. Kintara Therapeutics, Inc. (KTRA) has an RSI of 21.46 and experienced a 46% stock price drop over the past month. Aadi Bioscience, Inc. (AADI) reported interim trial results and saw a 54% decline in stock price over five days, with an RSI of 23.73. DURECT Corporation (DRRX) posted disappointing sales and a 9% stock price decrease over the past month, with an RSI of 27.92.

Portfolio Pulse from Avi Kapoor

December 18, 2023 | 12:39 pm

AMKR

APH

DIN

MU

NOC

Wall Street analysts have made recent stock picks with varying accuracy rates. Keybanc's Eric Gonzalez sees a 16% surge in Dine Brands Global (DIN), Truist Securities' William Stein predicts a 10% upside in Amphenol Corporation (APH), B. Riley Securities' Craig Ellis forecasts a 20% upside in Amkor Technology (AMKR), Wolfe Research's Myles Walton expects a 2% downside in Northrop Grumman (NOC), and B of A Securities' Vivek Arya anticipates a 17% surge in Micron Technology (MU). These ratings are based on recent financial reports and company developments.

Portfolio Pulse from Avi Kapoor

December 18, 2023 | 12:39 pm

SEDG

Goldman Sachs analyst Brian Lee has downgraded SolarEdge Technologies (NASDAQ:SEDG) from Neutral to Sell and set a price target of $77.

Portfolio Pulse from Benzinga Newsdesk

December 18, 2023 | 12:37 pm